Xcout Intel
Mosanna Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Mosanna Therapeutics among biotechnology companies — ranked by similarity to what Mosanna Therapeutics actually does, not by market-cap band.
Subscribe to see Mosanna Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Mosanna Therapeutics
Mosanna Therapeutics is a biopharmaceutical company with offices in Redwood City, California and Basel, Switzerland. The company focuses on developing novel treatments for metabolic and cardiovascular diseases. It launched with $80 million in funding to advance its clinical pipeline.
Mosanna Therapeutics at a glance
Mosanna Therapeutics is a biotechnology company headquartered in Switzerland. Its most recent funding round, Series A, raised $80M in June 2025. Xcout tracks 13 named people at Mosanna Therapeutics, including David Weber (President and Chief Executive Officer).
Mosanna Therapeutics leadership
- David WeberPresident and Chief Executive Officer
- David WhiteConsulting Chief Medical Officer (CMO)
- Sascha Oliver BucherCo-Founder & Partner, Forty51 Ventures
- Barbara FinnSVP Regulatory & Quality Assurance
- David SkarinskySVP Clinical Development
- Kevin KeeVP Pharmaceutical Development
7 more named people on record for Mosanna Therapeutics, with roles, board committees and tenure — see the full roster →
Mosanna Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $80M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Mosanna Therapeutics competitors
Ranked by semantic similarity — how close each company is to Mosanna Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Carmot Therapeutics, Inc. is a biopharmaceutical company headquartered in Berkeley, California, focused on discovering and developing innovative treatments for metabolic diseases and obesity.
Biotech
Akero Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company is dedicated to developing transformational therapies for metabolic dysfunction-associated steatohepatitis and other metabolic diseases.
Similar biotechnology company
Ferrosa Therapeutics AG is a Swiss biotechnology company founded in Basel, Switzerland, focusing on developing novel therapeutics to treat anemia and related conditions.
Similar biotechnology company
Metabolic Solutions Development Company is a private biotechnology and drug discovery company founded in 2006. The firm focuses on investigating novel molecular targets and developing therapeutics to treat diabetes, metabolic syndrome, and related conditions.
Similar biotechnology company
Myosana Therapeutics, Inc. is a biotechnology research company based in Seattle, Washington, pioneering non-viral gene therapy treatments for muscle diseases.
Similar biotechnology company
Mysthera Therapeutics AG is a biotechnology company headquartered in Basel, Switzerland, focused on developing first-in-class, oral therapeutics to treat inflammation-driven and related diseases.
Similar biotechnology company
Vaderis Therapeutics AG is a clinical-stage biotechnology company focused on developing novel treatments for severe vascular diseases. The company is headquartered in Basel, Switzerland.
Biotech
89bio is a clinical-stage biopharmaceutical company that develops innovative therapies for patients with liver and cardiometabolic diseases. The company utilizes its expertise in FGF21 as a master metabolic regulator to create treatments, such as pegozafermin, for conditions with limited or no approved therapeutic options.
Biotech
Bitterroot Bio is a privately held biotechnology company headquartered in Palo Alto, California, focused on the research and development of therapies for cardiovascular disease. The company operates as a biotechnology research firm and is engaged in clinical trials to evaluate its therapeutic pipeline.
Similar biotechnology company
Syntis Bio, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to revolutionizing oral therapies for obesity and metabolic diseases.
Similar biotechnology company
Edgewise Therapeutics is a biopharmaceutical company that develops novel therapeutics for individuals facing serious cardiovascular diseases, such as hypertrophic cardiomyopathy and heart failure. The company focuses on muscle science and precision therapies to address unmet medical needs in patients and families.
Similar biotechnology company
Caspian Therapeutics is a biopharmaceutical company developing menin inhibitors, such as its lead candidate KO-7246, as potential treatments for diabetes and other chronic metabolic diseases. The company focuses on a disease-modifying approach designed to restore the body's insulin-producing capacity through the expansion and enhanced function of pancreatic beta cells.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Mosanna Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Mosanna Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →